FDA approves BridgeBio’s Attruby for ATTR-CM treatment
The US FDA has approved BridgeBio Pharma’s Attruby (acoramidis) for treating adult individuals with ATTR-CM.
The US FDA has approved BridgeBio Pharma’s Attruby (acoramidis) for treating adult individuals with ATTR-CM.
What's Your Reaction?
